Inventor · disambiguated record
Nathan D. Waal
Also filed as: WAAL NATHAN · WAAL NATHAN D
31 granted patents·8 pending applications·245 citations·filing 2000–2024
97Inventor score
Files withVERTEX PHARMA29MERCK PATENT GMBH4SUNESIS PHARMACEUTICALS INC2LAUFFER DAVID1LAUFFER DAVID J1
Top patents by PatentIndex Score
39 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0396US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0495US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0595US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0695US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 0794US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 0893US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 0992US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 1092US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1192US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 1291US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 1391US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 1491US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 1590US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 1689US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 1788US11059826B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2019·Granted Jul 13, 2021·3 cites·49 claims
- 1886US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 1986US11572364B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2021·Granted Feb 7, 2023·1 cites·48 claims
- 2086US6806279B2Small-molecule inhibitors of interleukin-2SUNESIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 19, 2004·23 cites·19 claims
- 2184US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 2279US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 2377US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 2477US6376524B1Triphenyl compounds as interleukin-4 antagonistsSUNESIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 23, 2002·14 cites·15 claims
- 2577US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2676US12384790B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 2776US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 2876US11021465B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 1, 2021·0 cites·22 claims
- 2975US11008305B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 3069US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 3164US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 3254US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 3353US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3453US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3552US8269013B2Substituted pyrazole inhibitors of c-Met protein kinaseLI PAN·Filed 2010·Granted Sep 18, 2012·0 cites·18 claims
- 3644US2013190289A1Compounds and methods for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3743US2014065103A1Compounds and methods for the treatment or prevention of flaviviridae viral infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3837US8518938B2c-MET protein kinase inhibitorsLAUFFER DAVID J·Filed 2011·Granted Aug 27, 2013·0 cites·11 claims
- 3934US8481524B2c-MET protein kinase inhibitorsLAUFFER DAVID·Filed 2010·Granted Jul 9, 2013·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →